Rebiopsy Enhances Survival with Afatinib vs. Osimertinib in EGFR Exon 19 Deletion Non-Small Cell Lung Cancer: A Multicenter Study in Taiwan. - Kuo JS; Chang CY; Chang SC; Wei YF; Chen CY (Current oncology (Toronto, Ont.), 2025)